Building Conceptions of Cognitive Enhancement: University Students’ Views on the Effects of Pharmacological Cognitive Enhancers

References

• Akers, R. L. (1985). Deviant behavior: A social learning approach. Belmont, CA: Wadsworth.
   Google Scholar
• Benson, K., Flory, K., Humphreys, K. L., & Lee, S. S. (2015). Misuse of stimulant medication among college students: A comprehensive review and meta-analysis. Clinical Child and Family Psychology Review, 18(1), 50–76. doi:10.1007/s10567-014-0177-z
   PubMed Web of Science ®Google Scholar
• Cabrera, L. Y., Fitz, N. S., & Reiner, P. B. (2015). Reasons for comfort and discomfort with pharmacological enhancement of cognitive, affective, and social domains. Neuroethics, 8(2), 93–106. doi:10.1007/s12152-014-9222-3
   Web of Science ®Google Scholar
• Canadian Centre on Substance Abuse. (2016). Prescription stimulants (Canadian drug summary). Ottawa, ON, Canada: Canadian Centre on Substance Use and Addiction. ISBN 978-1-77178-351-4.
   Google Scholar
• Caviola, L., & Faber, N. S. (2015). Pills or push-ups? Effectiveness and public perception of pharmacological and non-pharmacological cognitive enhancement. Frontiers in Psychology, 6, 18521–18528. doi:10.3389/fpsyg.2015.01852
   Web of Science ®Google Scholar
• Cooper, W. O., Habel, L. A., Sox, C. M., Chan, K. A., Arbogast, P. G., Cheetham, T. C., … Ray, W. A. (2011). ADHD drugs and serious cardiovascular events in children and young adults. New England Journal of Medicine, 365(20), 1896–1904. doi:10.1056/NEJMoa1110212
   PubMed Web of Science ®Google Scholar
• Dalsgaard, S., Kvist, A. P., Leckman, J. F., Nielsen, H. S., & Simonsen, M. (2014). Cardiovascular safety of stimulants in children with Attention-Deficit/Hyperactivity disorder: A nationwide prospective cohort study. Journal of Child and Adolescent Psychopharmacology, 24(6),302–310. doi:10.1089/cap.2014.0020TQ4
   Google Scholar
• DeSantis, A. D., Webb, E. M., & Noar, S. M. (2008). Illicit use of prescription ADHD medications on a college campus: A multimethodological approach. Journal of American College Health, 57(3), 315–324. doi:10.3200/JACH.57.3.315-324
   PubMed Web of Science ®Google Scholar
• Farah, M. J., Smith, M. E., Ilieva, I., & Hamilton, R. H. (2014). Cognitive enhancement. Wiley Interdisciplinary Reviews: Cognitive Science, 5(1), 95–103. doi:10.1002/wcs.1250
   PubMed Web of Science ®Google Scholar
• Ford, J. A., & Ong, J. (2014). Non-medical use of prescription stimulants for academic purposes among college students: A test of social learning theory. Drug and Alcohol Dependence, 144, 279–282. doi:10.1016/j.drugalcdep.2014.09.011
   PubMed Web of Science ®Google Scholar
• Ford, J. A., & Pomykacz, C. (2016). Non-medical use of prescription stimulants: A comparison of college students and their same-age peers who do not attend college. Journal of Psychoactive Drugs, 48(4), 253–260. doi:10.1080/02791072.2016.1213471
   PubMed Web of Science ®Google Scholar
• Forlini, C., & Racine, E. (2012). Stakeholder perspectives and reactions to “academic” cognitive enhancement: Unsuspected meaning of ambivalence and analogies. Public Understanding of Science, 21(5), 606–625. doi:10.1177/0963662510385062
   PubMed Web of Science ®Google Scholar
• Franke, A. G., Bagusat, C., Rust, S., Engel, A., & Lieb, K. (2014). Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. European Archives of Psychiatry and Clinical Neuroscience, 264(Suppl 1), S83–S90. doi:10.1007/s00406-014-0537-1
   PubMedGoogle Scholar
• Garnier-Dykstra, L. M., Caldeira, K. M., Vincent, K. B., O’Grady, K. E., & Arria, A. M. (2012). Nonmedical use of prescription stimulants during college: Four-year trends in exposure opportunity, use, motives, and sources. Journal of American College Health, 60(3), 226–234. doi:10.1080/07448481.2011.589876
   PubMed Web of Science ®Google Scholar
• Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P., & Farah, M. J. (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456(7223), 702–705. doi:10.1038/456702a
   PubMed Web of Science ®Google Scholar
• Higgins, G. E., Mahoney, M., & Ricketts, M. L. (2009). Nonsocial reinforcement of the nonmedical use of prescription drugs: A partial test of social learning and self-control theories. Journal of Drug Issues, 39(4), 949–964. doi:10.1177/002204260903900409
   Web of Science ®Google Scholar
• Hildt, E., Lieb, K., & Franke, A. G. (2014). Life context of pharmacological academic performance enhancement among university students -A qualitative approach. BMC Medical Ethics, 15(23), 1–10. doi:10.1186/1472-6939-15-23
   PubMedGoogle Scholar
• Jensen, C., Forlini, C., Partridge, B., & Hall, W. (2016). Australian university students’ coping strategies and use of pharmaceutical stimulants as cognitive enhancers. Frontiers in Psychology, 7(277), 1–9. doi:10.3389/fpsyg.2016.00277
   PubMedGoogle Scholar
• Johnston, L. D., O’Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Miech, R. A. (2016). Monitoring the future national survey results on drug use, 1975–2015: Volume II, college students and adults ages 19-55. Ann Arbor, MI: Institute for Social Research, The University of Michigan.
   Google Scholar
• Judson, R., & Langdon, S. W. (2009). Illicit use of prescription stimulants among college students: Prescription status, motives, theory of planned behaviour, knowledge and self-diagnostic tendencies. Psychology, Health & Medicine, 14(1), 97–104. doi:10.1080/13548500802126723
   PubMed Web of Science ®Google Scholar
• Kolar, K. (2015). Study drugs “don’t make you smarter”: Acceptability evaluations of nonmedical prescription stimulant use among undergraduate students. Contemporary Drug Problems, 42(4), 314–330. doi:10.1177/0091450915614050
   Google Scholar
• Leos-Toro, C., Rynard, V., Murnaghan, D., Macdonald, J., & Hammond, D. (2019). Trends in cannabis use over time among Canadian youth: 2004 – 2014. Preventive Medicine, 118, 30–37. doi:10.1016/j.ypmed.2018.10.002
   PubMed Web of Science ®Google Scholar
• Macdonald, S., Stockwell, T., & Luo, J. (2011). The relationship between alcohol problems, perceived risks and attitudes toward alcohol policy in Canada. Drug and Alcohol Review, 30,652–658. doi:10.1111/j.1465-3362.2010.00259.x
   Google Scholar
• Maier, L. J., Ferris, J. A., & Winstock, A. R. (2018). Pharmacological cognitive enhancement among non-ADHD individuals — A cross-sectional study in 15 countries. International Journal of Drug Policy, 58, 104–112. doi:10.1016/j.drugpo.2018.05.009
   PubMed Web of Science ®Google Scholar
• Marraccini, M. E., Weyandt, L. L., Rossi, J. S., & Gudmundsdottir, B. G. (2016). Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration. Experimental and Clinical Psychopharmacology, 24(4), 269–284.
   PubMed Web of Science ®Google Scholar
• McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2005). Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction, 100(1), 96–106. doi:10.1111/j.1360-0443.2005.00944.x
   PubMed Web of Science ®Google Scholar
• McCabe, S. E., West, B. T., Teter, C. J., & Boyd, C. J. (2014). Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots. Addictive Behaviors, 39(7), 1176–1182. doi:10.1016/j.addbeh.2014.03.008
   PubMed Web of Science ®Google Scholar
• Müller, U., Rowe, J. B., Rittman, T., Lewis, C., Robbins, T. W., & Sahakian, B. J. (2013). Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology, 64, 490–495. doi:10.1016/j.neuropharm.2012.07.009
   PubMed Web of Science ®Google Scholar
• Partridge, B., Bell, S., Lucke, J., & Hall, W. (2013). Australian university students’ attitudes towards the use of prescription stimulants as cognitive enhancers: Perceived patterns of use, efficacy and safety. Drug and Alcohol Review, 32(3), 295–302. doi:10.1111/dar.12005
   PubMed Web of Science ®Google Scholar
• Peralta, R. L., & Steele, J. L. (2010). Nonmedical prescription drug use among US college students at a midwest university: A partial test of social learning theory. Substance Use & Misuse, 45, 865–887. doi:10.3109/10826080903443610
   PubMed Web of Science ®Google Scholar
• Pighi, M., Ferrari, S., Pingani, L., Pontoni, G., Rigatelli, M., & Galeazzi, G. M. (2015). Neuroenhancers use amongst Italian medical students. A survey. European Psychiatry, 30(Suppl 1), 321. doi:10.1016/S0924-9338(15)30256-X
   Web of Science ®Google Scholar
• Ponnet, K., Wouters, E., Walrave, M., Heirman, W., & Van Hal, G. (2015). Predicting students’ intention to use stimulants for academic performance enhancement. Substance Use & Misuse, 50, 275–282. doi:10.3109/10826084.2014.952446
   PubMed Web of Science ®Google Scholar
• Rabiner, D. L., Anastopoulos, A. D., Costello, E. J., Hoyle, R. H., Mccabe, S. E., & Swartzwelder, H. S. (2009). Motives and perceived consequences of nonmedical ADHD medication use by college students: Are students treating themselves for. Journal of Attention Disorders, 13(3), 259–270. doi:10.1177/1087054708320399
   PubMed Web of Science ®Google Scholar
• Racine, É., & Forlini, C. (2010). Cognitive enhancement, lifestyle choice or misuse of prescription drugs? Ethics blind spots in current debates. Neuroethics, 3, 1–4. doi:10.1007/s12152-008-9023-7
   Google Scholar
• Ram, S., Hussainy, S., Henning, M., Jensen, M., & Russell, B. (2016). Prevalence of cognitive enhancer use among New Zealand tertiary students. Drug and Alcohol Review, 35(3), 345–351. doi:10.1111/dar.12294
   PubMed Web of Science ®Google Scholar
• Ram, S., Hussainy, S., Henning, M., Stewart, K., Jensen, M., & Russell, B. (2017). Attitudes toward cognitive enhancer use among New Zealand tertiary students. Substance Use & Misuse, 52, 1387–1392. doi:10.1080/10826084.2017.1281313
   PubMed Web of Science ®Google Scholar
• Repantis, D., Schlattmann, P., Laisney, O., & Heuser, I. (2010). Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research, 62(3), 187–206. doi:10.1016/j.phrs.2010.04.002
   PubMed Web of Science ®Google Scholar
• Riddell, C., Jensen, C., & Carter, O. (2018). Cognitive enhancement and coping in an Australian university student sample. Journal of Cognitive Enhancement, 2(1), 63–69. doi:10.1007/s41465-017-0046-z
   Google Scholar
• Ripley, L. (2005). “Best” practices in prevention for youth - Literature Review. Vancouver Coastal Health. Vancouver, BC, Canada: Vancouver Coastal Health, Youth Addictions and Prevention.
   Google Scholar
• Rosenfield, D., Hébert, P. C., Stanbrook, M. B., The Editorial Advisory Team, Flegel, K., & MacDonald, N. E. (2011). Time to address stimulant abuse on our campuses. CMAJ, 183(12),1345. doi:10.1503/cmaj.111149
   Google Scholar
• Sattler, S., Forlini, C., Racine, É., & Sauer, C. (2013). Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement. PLoS One, 8(8), 1–12. doi:10.1371/journal.pone.0071452
   Web of Science ®Google Scholar
• Singh, I., Bard, I., & Jackson, J. (2014). Robust resilience and substantial interest: A survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PLoS One, 9(10), e105969. doi:10.1371/journal.pone.0105969
   PubMed Web of Science ®Google Scholar
• Statistics Canada. (2016). NHS profile, 2011. Ottawa, Ontario: Statistics Canada Catalogue no 99-004-XWE. November 23 Retrieved from https://www12.statcan.gc.ca/nhs-enm/2011/dp-pd/prof/index.cfm?Lang=E (accessed April 15, 2018).
   Google Scholar
• Stoeber, J., & Hotham, S. (2016). Perfectionism and attitudes toward cognitive enhancers (“smart drugs”). Personality and Individual Differences, 88, 170–174. doi:10.1016/j.paid.2015.09.011
   Web of Science ®Google Scholar
• Thoër, C., Robitaille, M., & Duetto, A. (2014). Le rôle d’Internet dans la construction des risques relatifs à la consommation détournée de médicaments par des jeunes adultes québécois. Le Temps Des Médias, 23(2), 144–147. doi:10.3917/tdm.023.0144
   Google Scholar
• Wild, T. C., Pauly, B., Belle-Isle, L., Cavalieri, W., Elliott, R., Strike, C., … Hyshka, E. (2017). Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000 – 2015. International Journal of Drug Policy, 45, 9–17. doi:10.1016/j.drugpo.2017.03.014
   PubMed Web of Science ®Google Scholar